Original Article

Impact of Clinical Decision Support Software on the Prevalence of Drug-Drug Interactions in an Emergency Ward: A Quasi-Experimental Before-and-After Study

Abstract

Background: Drug interactions present significant challenges in emergency departments due to the diverse patient population and the complexity of medical conditions. These interactions threaten patient safety and increase healthcare costs. Strategies such as Clinical Decision Support Systems (CDSS) and audit-and-feedback mechanisms are essential for alerting physicians to potential medication risks.
Methods: A quasi-experimental before-and-after study was conducted in the emergency department of Ghaem Hospital in Mashhad. Phase 1 (June–August 2024) retrospectively analyzed drug interactions for 482 patients using Lexidrug 2024. To ensure comparability and minimize ascertainment bias, the Phase 1 analysis was restricted to interactions involving the 150 most commonly used medications in the emergency ward, which were included in the Phase 2 software. Phase 2 (October–December 2024) assessed 482 patients using a locally developed software (Idea Pardazan Asr Hoshmand Etminan) combined with a weekly audit-and-feedback intervention sent to physicians. Major interactions, classified as Category X (life-threatening) and Category D (clinically significant), were compared using the Chi-square test in SPSS version 12.
Results: Phase 1 recorded 42 Category X interactions (8.7%) and 118 Category D interactions (24.5%). In Phase 2, Category X interactions decreased to 32 (6.6%), but this reduction was not statistically significant (P = 0.276). However, Category D interactions significantly decreased to 45 (9.3%) in Phase 2 (P < 0.01). There were no significant differences in interaction rates between academic and non-academic specialists.
Conclusion: The implementation of the software, combined with weekly feedback reports, significantly reduced clinically significant (Category D) interactions. However, the lack of a statistically significant reduction in life-threatening (Category X) interactions suggests that weekly feedback may be insufficient for critical alerts requiring immediate action. Future iterations should focus on real-time integration into clinical workflows to address urgent patient safety threats.

Zeitlinger M. Drug Interactions. In: Müller M, editor. Clinical Pharmacology: Current Topics and Case Studies. 2nd ed. Cham: Springer International Publishing; 2016. p. 265-92.

Bushra R, Aslam N, Khan AY. Food-drug interactions. Oman Med J. 2011;26(2):77-83.

Cascorbi I. Drug interactions--principles, examples and clinical consequences. Dtsch Arztebl Int. 2012;109(33-34):546-55; quiz 556.

Medscape drug interactions checker [Internet]. Medscape. Available from: https://reference.medscape.com/drug-interactionchecker

Drugs.com [Internet]. Drug interaction checker. Available from: www.drugs.com/drug_interactions.html

Lexicomp Drug Interactions [Internet]. In: Lexidrug. Hudson, OH: Wolters Kluwer Clinical Drug Information, Inc.; Available from: https://www.wolterskluwer.com/en/solutions/uptodate/pro/lexidrug

Roncato R, Dal Cin L, Mezzalira S, Comello F, De Mattia E, Bignucolo A, et al. FARMAPRICE: A Pharmacogenetic Clinical Decision Support System for Precise and Cost-Effective Therapy. Genes (Basel). 2019;10(4):276.

Jung SY, Hwang H, Lee K, Lee HY, Kim E, Kim M, et al. Barriers and Facilitators to Implementation of Medication Decision Support Systems in Electronic Medical Records: Mixed Methods Approach Based on Structural Equation Modeling and Qualitative Analysis. JMIR Med Inform. 2020;8(7):e18758.

Hingorani R, Mahmood M, Alweis R. Improving antibiotic adherence in treatment of acute upper respiratory infections: a quality improvement process. J Community Hosp Intern Med Perspect. 2015;5(3):27472.

Sutton RT, Pincock D, Baumgart DC, Sadowski DC, Fedorak RN, Kroeker KI. An overview of clinical decision support systems: benefits, risks, and strategies for success. NPJ Digit Med. 2020;3:17.

Sintchenko V, Coiera E, Iredell JR, Gilbert GL. Comparative impact of guidelines, clinical data, and decision support on prescribing decisions: an interactive web experiment with simulated cases. J Am Med Inform Assoc. 2004;11(1):71-7.

Khalifa M, Zabani I. Improving Utilization of Clinical Decision Support Systems by Reducing Alert Fatigue: Strategies and Recommendations. Stud Health Technol Inform. 2016;226:51-4.

Ash JS, Sittig DF, Campbell EM, Guappone KP, Dykstra RH. Some unintended consequences of clinical decision support systems. AMIA Annu Symp Proc. 2007;2007:26-30.

Institute for Safe Medication Practices (ISMP) [Internet]. Available from: https://home.ecri.org/pages/ismp

Alavi-Moghaddam M, SistaniZad M, Shams A, Ghodsi Ghasem Abadi R. Evaluating the Frequency and Pattern of Drug Interactions in Patients Admitted To the Emergency Department; a Cross-Sectional Study. J Pract Emerg Med. 2020;7(1):e22.

Okuno MF, Cintra RS, Vancini-Campanharo CR, Batista RE. Drug interaction in the emergency service. Einstein (Sao Paulo). 2013;11(4):462-6.

Hasanloei V, Amin ME, Hamdolah S, Aysa H, editors. Drug–Drug Interactions Prevalence in Intensive Care Unit Patients of a University Hospital in Iran. Bulletin of Environment, Pharmacology and Life Sciences 2014;3:87-91.

Sepehri G, Khazaelli P, Dahooie FA, Sepehri E, Dehghani MR. Prevalence of potential drug interactions in an Iranian general hospital. Indian J Pharm Sci. 2012;74(1):75-9.

Namazi S, Pourhatami S, Borhani-Haghighi A, Roosta S. Incidence of Potential Drug-Drug Interaction and Related Factors in Hospitalized Neurological Patients in two Iranian Teaching Hospitals. Iran J Med Sci. 2014;39(6):515-21.

Hosseini E, Shojaei L, Karimpour H, Shahbazi F. Potential Drug-Drug Interactions in Critically Ill Medical Patients: A Cross-Sectional Study. J Pharm Care. 2019;6(3-4):52-57.

Admassie E, Melese T, Mequanent W, Hailu W, Srikanth BA. Extent of poly-pharmacy, occurrence and associated factors of drug-drug interaction and potential adverse drug reactions in Gondar Teaching Referral Hospital, North West Ethiopia. J Adv Pharm Technol Res. 2013;4(4):183-9.

Dirin MM, Mousavi S, Afshari AR, Tabrizian K, Ashrafi MH. Potential drug-drug interactions in prescriptions dispensed in community and hospital pharmacies in East of Iran. J Res Pharm Pract. 2014;3(3):104-7.

Mehrpooya M, Taher A, Golgiri A, Mohammadi Y, Ahmadimoghaddam D. Evaluation of the Drug Interactions Frequency and Their Related Factors in Hospitalized Patients of the Intensive Care Unit in the Hamadan Besat Hospital. Avicenna J Nurs Midwifery Care. 2021;29(3):171-80.

Villa Zapata L, Subbian V, Boyce RD, Hansten PD, Horn JR, Gephart SM, et al. Overriding Drug-Drug Interaction Alerts in Clinical Decision Support Systems: A Scoping Review. Stud Health Technol Inform. 2022;290:380-4.

Felisberto M, Lima GDS, Celuppi IC, Fantonelli MDS, Zanotto WL, Dias de Oliveira JM, et al. Override rate of drug-drug interaction alerts in clinical decision support systems: A brief systematic review and meta-analysis. Health Informatics J. 2024;30(2):14604582241263242.

Files
IssueVol 13, No 4 (Autumn 2025) QRcode
SectionOriginal Article(s)
Keywords
Drug Interactions Emergency Department Software Lexidrug Clinical Decision Support System Audit and Feedback

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
Ebrahimpour M, Tavakolian A, Malaekeh-Nikouei A, Ebnehoseini Z, Vakili Arki H, Elyasi S. Impact of Clinical Decision Support Software on the Prevalence of Drug-Drug Interactions in an Emergency Ward: A Quasi-Experimental Before-and-After Study. J Pharm Care. 2025;13(4):260-268.